Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2052 ARTÍCULOS , VIENDO DEL 316 AL 330

Stress-Induced Depression and Alzheimer's Disease: Focus on Astrocytes

Dolotov OV, Inozemtseva LS, Myasoedov NF, Grivennikov IA.

Int J Mol Sci. 2022 Apr 30;23(9):4999. doi: 10.3390/ijms23094999.

A(2A) Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity?

Merighi S, Nigro M, Travagli A, Pasquini S, Borea PA, Varani K, Vincenzi F, Gessi S.

Int J Mol Sci. 2022 May 2;23(9):5056. doi: 10.3390/ijms23095056.

A Narrative Review of the Effects of Citrus Peels and Extracts on Human Brain Health and Metabolism

Matsuzaki K, Nakajima A, Guo Y, Ohizumi Y.

Nutrients. 2022 Apr 28;14(9):1847. doi: 10.3390/nu14091847.

Recent trends of bioconjugated nanomedicines through nose-to-brain delivery for neurological disorders

Agnihotri TG, Jadhav GS, Sahu B, Jain A.

Drug Deliv Transl Res. 2022 Dec;12(12):3104-3120. doi: 10.1007/s13346-022-01173-y. Epub 2022 May 15.

Microbiota-gut-brain axis in the Alzheimer's disease pathology - an overview

Giridharan VV, Barichello De Quevedo CE, Petronilho F.

Neurosci Res. 2022 Aug;181:17-21. doi: 10.1016/j.neures.2022.05.003. Epub 2022 May 14.

Brexpiprazole-Associated Pisa Syndrome (Pleurothotonus) in a Patient With Dementia

Nagai Y, Yamazaki T, Sugita T, Shibata N.

Clin Neuropharmacol. 2022 May-Jun 01;45(3):72-73. doi: 10.1097/WNF.0000000000000500. Epub 2022 Apr 14.

The amyloid precursor protein: a converging point in Alzheimer's disease

Delport A, Hewer R.

Mol Neurobiol. 2022 Jul;59(7):4501-4516. doi: 10.1007/s12035-022-02863-x. Epub 2022 May 17.

A novel approach to type 3 diabetes mechanism: The interplay between noncoding RNAs and insulin signaling pathway in Alzheimer's disease

Moayedi K, Orandi S, Ebrahimi R, Tanhapour M, Moradi M, Abbastabar M, Golestani A.

J Cell Physiol. 2022 Jul;237(7):2838-2861. doi: 10.1002/jcp.30779. Epub 2022 May 17.

Are mitophagy enhancers therapeutic targets for Alzheimer's disease?

Pradeepkiran JA, Hindle A, Kshirsagar S, Reddy PH.

Biomed Pharmacother. 2022 May;149:112918. doi: 10.1016/j.biopha.2022.112918. Epub 2022 Apr 4.

Amyloid-beta Targeted Therapeutic Approaches for Alzheimer's Disease: Long Road Ahead

Dai Y, Lei C, Zhang Z, Qi Y, Lao K, Gou X.

Curr Drug Targets. 2022;23(11):1040-1056. doi: 10.2174/1389450123666220421124030.

Healthcare Costs Associated with Potentially Inappropriate Medication Prescribing Detected by Computer Algorithm Among Older Patients

Pagès A, Costa N, Mounié M, Cestac P, De Souto Barreto P, Rolland Y, Vellas B, Molinier L, Juillard-Condat B; MAPT/DSA Group.

Drugs Aging. 2022 May;39(5):367-375. doi: 10.1007/s40266-022-00938-x. Epub 2022 May 24.

Mechanisms of Mitochondrial Malfunction in Alzheimer's Disease: New Therapeutic Hope

Nabi SU, Khan A, Siddiqui EM, Rehman MU, Alshahrani S, Arafah A, Mehan S, Alsaffar RM, Alexiou A, Shen B.

Oxid Med Cell Longev. 2022 May 14;2022:4759963. doi: 10.1155/2022/4759963. eCollection 2022.

Targeting Necroptosis as a Promising Therapy for Alzheimer's Disease

Zhao W, Liu Y, Xu L, He Y, Cai Z, Yu J, Zhang W, Xing C, Zhuang C, Qu Z.

ACS Chem Neurosci. 2022 Jun 15;13(12):1697-1713. doi: 10.1021/acschemneuro.2c00172. Epub 2022 May 23.

Increasing Brain Gamma Activity Improves Episodic Memory and Restores Cholinergic Dysfunction in Alzheimer's Disease

Benussi A, Cantoni V, Grassi M, Brechet L, Michel CM, Datta A, Thomas C, Gazzina S, Cotelli MS, Bianchi M, Premi E, Gadola Y, Cotelli M, Pengo M, Perrone F, Scolaro M, Archetti S, Solje E, Padovani A, Pascual-Leone A, Borroni B.

Ann Neurol. 2022 Aug;92(2):322-334. doi: 10.1002/ana.26411. Epub 2022 Jun 6.

Latest progress in the development of multitarget ligands for Alzheimer's disease based on the Hantzsch reaction

Ismaili L, Bernard PJ, Refouvelet B.

Future Med Chem. 2022 Jul;14(13):943-946. doi: 10.4155/fmc-2022-0080. Epub 2022 May 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias